Publications by authors named "Carrie B Lee"

22Publications

Chemotherapy Following PD-1 Inhibitor Blockade in Patients with Unresectable Stage III/Stage IV Metastatic Melanoma: A Single Academic Institution Experience.

Oncology 2020 3;98(3):174-178. Epub 2019 Dec 3.

Department of Medicine, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000504578DOI Listing
March 2020

The incidence of radiation necrosis following stereotactic radiotherapy for melanoma brain metastases: the potential impact of immunotherapy.

Anticancer Drugs 2017 07;28(6):669-675

aUNC Lineberger Comprehensive Cancer Center Departments of bRadiation Oncology cMedicine dNeurosurgery, University of North Carolina, Chapel Hill, North Carolina, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CAD.0000000000000497DOI Listing
July 2017

Cardiac Toxicity After Radiotherapy for Stage III Non-Small-Cell Lung Cancer: Pooled Analysis of Dose-Escalation Trials Delivering 70 to 90 Gy.

J Clin Oncol 2017 May 23;35(13):1387-1394. Epub 2017 Jan 23.

Kyle Wang, Michael J. Eblan, Matthew Lipner, Timothy M. Zagar, Panayiotis Mavroidis, Carrie B. Lee, Brian C. Jensen, Julian G. Rosenman, and Lawrence B. Marks, University of North Carolina Hospitals; Allison M. Deal and Yue Wang, Lineberger Comprehensive Cancer Center Biostatistics Core, University of North Carolina Hospitals, Chapel Hill; Thomas E. Stinchcombe, Duke University Hospitals, Durham, NC; and Mark A. Socinski, Florida Hospital Cancer Institute, Orlando, FL.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.70.0229DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5455462PMC
May 2017

Use of Susceptibility-Weighted Imaging (SWI) in the Detection of Brain Hemorrhagic Metastases from Breast Cancer and Melanoma.

J Comput Assist Tomogr 2016 Sep-Oct;40(5):803-5

From the *Department of Radiology, New York University Medical Center, New York, NY; and †Division of Hematology and Oncology, Department of Medicine, UNC at Chapel Hill, Chapel Hill, NC; ‡Neuroradiology Section, Department of Radiology, The University of North Carolina School of Medicine, Chapel Hill, NC.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/RCT.0000000000000420DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5027959PMC
January 2017

Left Ventricular Dysfunction After Treatment With Ipilimumab for Metastatic Melanoma.

Am J Ther 2016 Nov/Dec;23(6):e1925-e1928

1Department of Pharmacy, University of North Carolina Medical Center, Chapel Hill, NC; 2Division of Cardiology, University of North Carolina Medical Center, Chapel Hill, NC; 3UNC School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC; 4UNC McAllister Heart Institute, Chapel Hill, NC; 5Center for Heart and Vascular Care, University of North Carolina Medical Center, Chapel Hill, NC; 6Department of Medicine, University of North Carolina Medical Center, Chapel Hill, NC; and 7Lineberger Comprehensive Cancer Center, Chapel Hill, NC.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MJT.0000000000000430DOI Listing
February 2017

Alterations of LKB1 and KRAS and risk of brain metastasis: comprehensive characterization by mutation analysis, copy number, and gene expression in non-small-cell lung carcinoma.

Lung Cancer 2014 Nov 30;86(2):255-61. Epub 2014 Aug 30.

The Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, United States; Department of Internal Medicine, Division of Hematology/Oncology, Multidisciplinary Thoracic Oncology Program, University of North Carolina at Chapel Hill, United States. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2014.08.013DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4362696PMC
November 2014

A retrospective analysis of VeriStrat status on outcome of a randomized phase II trial of first-line therapy with gemcitabine, erlotinib, or the combination in elderly patients (age 70 years or older) with stage IIIB/IV non-small-cell lung cancer.

J Thorac Oncol 2013 Apr;8(4):443-51

Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, 170 Manning Drive, Physician’s Office Building, 3rd Floor, Chapel Hill, NC 27599-7305, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0b013e3182835577DOI Listing
April 2013

A randomized phase II trial of first-line treatment with gemcitabine, erlotinib, or gemcitabine and erlotinib in elderly patients (age ≥70 years) with stage IIIB/IV non-small cell lung cancer.

J Thorac Oncol 2011 Sep;6(9):1569-77

Division of Hematology/Oncology, Multidisciplinary Thoracic Oncology Program, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599-7, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0b013e3182210430DOI Listing
September 2011

Late complications of high-dose (>/=66 Gy) thoracic conformal radiation therapy in combined modality trials in unresectable stage III non-small cell lung cancer.

J Thorac Oncol 2009 Jan;4(1):74-9

Division of Hematology/Oncology, Multidisciplinary Thoracic Oncology Program, Lineberger Comprehensive Cancer Center at University of North Carolina at Chapel Hill, North Carolina, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0b013e3181915028DOI Listing
January 2009

Long-term follow-up of a phase I/II trial of dose escalating three-dimensional conformal thoracic radiation therapy with induction and concurrent carboplatin and paclitaxel in unresectable stage IIIA/B non-small cell lung cancer.

J Thorac Oncol 2008 Nov;3(11):1279-85

Division of Hematology/Oncology, Multidisciplinary Thoracic Oncology Program, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599-7305, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0b013e31818b1971DOI Listing
November 2008

Vascular endothelial growth factor receptor tyrosine kinase inhibitors in non-small cell lung cancer: a review of recent clinical trials.

Rev Recent Clin Trials 2007 May;2(2):117-20

Multidisciplinary Thoracic Oncology Program, Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC 27599-7305, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2174/157488707780599401DOI Listing
May 2007

Phase I trial of nanoparticle albumin-bound paclitaxel in combination with gemcitabine in patients with thoracic malignancies.

J Thorac Oncol 2008 May;3(5):521-6

Multidisciplinary Thoracic Oncology Program, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599-7305, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0b013e31816de2a7DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2860395PMC
May 2008

Therapeutic advances in local-regional therapy for stage III non-small-cell lung cancer: evolving role of dose-escalated conformal (3-dimensional) radiation therapy.

Clin Lung Cancer 2006 Nov;8(3):195-202

Multidisciplinary Thoracic Oncology Program, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, NC 27599, USA.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S152573041170497
Publisher Site
http://dx.doi.org/10.3816/CLC.2006.n.047DOI Listing
November 2006

Current approaches to advanced-stage non-small-cell lung cancer: first-line therapy in patients with a good functional status.

Clin Lung Cancer 2006 May;7 Suppl 4:S111-7

Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill 27599-7305, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3816/clc.2006.s.002DOI Listing
May 2006

Current and evolving treatment options for limited stage small cell lung cancer.

Curr Opin Oncol 2006 Mar;18(2):162-72

Multidisciplinary Thoracic Oncology Program, Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, 27599, USA.

View Article

Download full-text PDF

Source
https://insights.ovid.com/crossref?an=00001622-200603000-000
Publisher Site
http://dx.doi.org/10.1097/01.cco.0000208790.45312.25DOI Listing
March 2006